Form 4: Harvard Bioscience CEO James W. Green Disposes of Shares to Cover Tax Obligations

James W. Green, CEO of Harvard Bioscience, disposed of shares to cover tax obligations related to vested restricted stock units.

Summary

• On March 19, 2025, James W. Green, the CEO of Harvard Bioscience, disposed of 38,413 shares of common stock to satisfy tax withholding obligations.
• The shares were related to restricted stock units (RSUs) that vested on the same date.
• The transaction was executed at a price of $0.6886 per share.
• Following the transaction, Green beneficially owns 2,845,088 shares of Harvard Bioscience common stock.
• This total includes 117,713 RSUs vesting on December 29, 2025, 143,198 RSUs vesting in two equal installments on March 19, 2026 and 2027, 554,407 RSUs with performance-based vesting conditions, and 2,029,770 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, with neutral sentiment.

Future Outlook

The document provides information on future vesting dates for Green's RSUs, indicating potential future increases in his share ownership.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the CEO's personal tax obligations and a relatively small number of shares compared to his total holdings.

Key Dates

Keywords

Harvard Bioscience, HBIO, James W. Green, CEO, Form 4, Stock Disposal, Restricted Stock Units, RSUs, Beneficial Ownership, Tax Withholding